Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remicade onset of efficacy in RA
NCT00794898Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2003
- Primary completion
- Apr 2004
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of infliximab in rheumatoid arthritis (RA), sponsored by Merck & Co.. Started Jul 2003; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00794898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794898.